Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
American Journal of Preventive Cardiology · 2026-08 · 28 · 101494
DOI: 10.1016/j.ajpc.2026.101494 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-08. Verfasst von Maria A Pabon und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association, National Institute on Deafness and Other Communication Disorders, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Background
Adverse pregnancy outcomes (APO) are associated with increased cardiovascular disease (CVD) risk. However, studies evaluating preconception cardiometabolic risk factors and the development of APO are lacking in high-risk, understudied groups including the Hispanic/Latina population.
Methods
We examined the odds of APO associated with preconception cardiometabolic markers in the prospective cohort of Hispanic Community Health Study/Study of Latinos (HCHS/SOL). APO was defined as self-reported hypertensive disorders of pregnancy (HDP) or gestational diabetes (GDM). Metabolic syndrome was defined per NCEP-ATP III criteria. Women reporting at least 1 pregnancy between baseline (2008-2011) and visit 2 (2014-2017) were included. Multivariate logistic regressions were used to determine the odds of APO.
Results
Among 529 participants, 111 (21 %) reported an APO. In adjusted models, higher preconception systolic blood pressure (SBP), body mass index, waist circumference, HbA1c, and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) were associated with increased odds of APO. A dose-response relationship in metabolic syndrome components, with two and three or more components significantly increasing the odds of developing an APO (adjusted OR 2.50 (1.07, 5.84) and 3.39 (1.37, 8.42)).
Conclusion
High-risk preconception cardiometabolic abnormalities increase the odds of developing an APO in Hispanic/Latina women, with a dose-response relationship by the number of metabolic syndrome components. Early identification and intervention are crucial to reduce APOs and their long-term cardiovascular consequences in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Women's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, OH, USA.
- The Carl and Edyth Lindner Center for Research and Education, The Christ Hospital, Cincinnati, OH, USA.
- Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.
- Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Kentucky College of Medicine, Lexington, KY, USA.
- Department of Pediatrics, Interdisciplinary Stem Cell Institute, Miller School of Medicine, Miami, FL, USA.
Förderung
- American Heart Association
- National Institute on Deafness and Other Communication Disorders
- U.S. Department of Health and Human Services
- National Institute of Dental and Craniofacial Research
- Office of Dietary Supplements
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke
- National Heart, Lung, and Blood Institute
Zitieren
APA
Pabon, M. A., Tapp, D. N., Pico, M., Vladutiu, C. J., Schmidt, C., DeFranco, E., Kulandavelu, S., Elfassy, T., Minissian, M. B., Bello, N. A., Bairey Merz, C. N., Makarem, N., Meyer, M. L., Perreira, K. M., Teng, Y., Daviglus, M., Kominiarek, M. A., Rodríguez, C. J., Hurwitz, B. E., …, & Quesada, O. (2026). Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). American Journal of Preventive Cardiology, 28, 101494. https://doi.org/10.1016/j.ajpc.2026.101494
Vancouver
Pabon MA, Tapp DN, Pico M, Vladutiu CJ, Schmidt C, DeFranco E, et al. Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). American Journal of Preventive Cardiology. 2026;28:101494. doi:10.1016/j.ajpc.2026.101494
BibTeX
@article{Pabon2026,
author = {Pabon, Maria A and Tapp, Danielle N and Pico, Madison and Vladutiu, Catherine J and Schmidt, Christian and DeFranco, Emily and Kulandavelu, Shathiyah and Elfassy, Tali and Minissian, Margo B and Bello, Natalie A and Bairey Merz, C Noel and Makarem, Nour and Meyer, Michelle L and Perreira, Krista M and Teng, Yanping and Daviglus, Martha and Kominiarek, Michelle A and Rodríguez, Carlos J and Hurwitz, Barry E and Talavera, Gregory A and Cheng, Susan and Quesada, Odayme},
title = {Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)},
journal = {American Journal of Preventive Cardiology},
year = {2026},
volume = {28},
pages = {101494},
doi = {10.1016/j.ajpc.2026.101494}
}
EUVIMED